Tumor Stem Cells in Cancer Biology, Prevention, and Therapy (P01)

The summary for the Tumor Stem Cells in Cancer Biology, Prevention, and Therapy (P01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Tumor Stem Cells in Cancer Biology, Prevention, and Therapy (P01): Purpose. The objective of this Funding Opportunity Announcement (FOA) is to stimulate research on tumor stem cell biology, including the identification and characterization of specific genetic and functional signatures (e.g., biomarkers) of tumor stem cells. The overall goal is the translation of basic research findings into clinical practice in the contexts of both hematological and solid tumor malignancies. Applications submitted in response to this RFA must propose interdisciplinary Program Projects that comprehensively address novel aspects of the biology of tumor stem cells (tumor initiating cells) combined with the meaningful translation of basic research findings into a clinically-relevant context. Each application must propose at least three individual (albeit connected) research projects pertinent to a single unifying research theme. At least one of these projects must address basic aspects of tumor cell biology and at least one project must center on translation of such basic research findings into a clinically-relevant context. The other projects may focus on either basic or translational research or combine both aspects. It is expected that the proposed Program Projects will involve substantive collaborative arrangements between basic and translational researchers. Therefore, applicants are encouraged to consider the Multiple Principal Investigators option.
Federal Grant Title: Tumor Stem Cells in Cancer Biology, Prevention, and Therapy (P01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-08-020
Type of Funding: Grant
CFDA Numbers: 93.39393.394
CFDA Descriptions: Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research
Current Application Deadline: No deadline provided
Original Application Deadline: Jul 10, 2008
Posted Date: Mar 26, 2008
Creation Date: Mar 26, 2008
Archive Date: Aug 10, 2008
Total Program Funding: $2,700,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.395 -- Cancer Treatment Research
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments For profit organizations other than small businesses Private institutions of higher education
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster